Related Experiment Videos
Emerging therapies in metastatic bone pain
Flaminia Coluzzi1, Ilenia Mandatori, Consalvo Mattia
1SAPIENZA University of Rome, Department of Medical and Surgical Sciences and Biotechnologies, Italy. flaminia.coluzzi@uniroma1.it
Expert Opinion on Emerging Drugs
|May 7, 2011
Summary
New drugs targeting molecular mechanisms in bone metastases offer improved pain relief beyond palliative care. Future therapies aim to break the cycle of bone metastatic disease, expanding treatment options within a decade.
Area of Science:
- Oncology
- Pharmacology
- Pain Management
Background:
- Current treatments for metastatic bone pain are primarily palliative.
- Recent discoveries in bone metastasis molecular mechanisms reveal new therapeutic targets.
- This review updates preclinical and clinical data on novel drugs for metastatic bone pain.
Purpose of the Study:
- To review emerging therapeutic targets and drugs for metastatic bone pain.
- To provide an update on preclinical and clinical data for new bone-targeting agents.
- To discuss novel strategies for managing cancer-induced bone pain.
Main Methods:
- Review of preclinical and clinical data on new drugs for metastatic bone pain.
- Analysis of emerging molecular targets involved in bone metastases and pain.
- Evaluation of drugs targeting cancer cells, bone microenvironment, and nociceptors.
Main Results:
- Bisphosphonates are current standard-of-care for bone metastases, offering anti-resorptive and analgesic effects.
- Emerging targets include osteoprotegerin, RANK/RANKL, cathepsin K, Wnt/beta-catenin, sclerostin, Src, nerve growth factor, endothelin A, TGF-beta, CXCR4, TPRV1, Trk, and cannabinoid receptors.
- These novel agents aim to disrupt the cancer cell-bone microenvironment interaction.
Conclusions:
- Emerging therapies are expected to significantly increase treatment options for bone metastases in the next decade.
- Most novel drugs are in early developmental stages.
- Further clinical trials are essential to confirm the efficacy and safety of these new treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...